Combined Saphenous Nerve and IPACK Blocks Versus Infiltration Analgesia After Anterior Cruciate Ligament Reconstruction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-11-01

Study Completion Date

2020-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A lot of patient have posterior knee pain after ACL reconstruction despite saphenous nerve block. Recently a new block has been described, know as IPACK block (interspace between the popliteal artery and the capsule of the posterior knee). The objective of this randomized controlled double-blinded trial is to assess whether a combined saphenous nerve block with IPACK block is more effective for the postoperative pain than a local infiltration analgesia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

IPACK or Selective Tibial Nerve Block for ACL Reconstruction With an Adductor Canal Block

NCT05303233

Analgesia

COMPLETED NA

IPACK Versus Popliteal Sciatic Nerve Block in ACL Reconstruction

NCT03983941

Anterior Cruciate Ligament Tear

TERMINATED PHASE3

Comparison of Two Different Regional Analgesia Techniques for Patients Undergoing Total Knee Arthroplasty

NCT06179641

Analgesia Arthropathy of Knee Postoperative Pain

RECRUITING NA

Femoral Triangle + IPACK Blocks for ACL Reconstruction Analgesia

NCT05068063

Anterior Cruciate Ligament Rupture Acute Pain Pain, Postoperative +1 more

UNKNOWN NA

Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following ACL Reconstruction With Bone Patellar Tendon Bone Autograft:

NCT05286307

Anterior Cruciate Ligament Rupture

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The saphenous nerve and the iPACK will be performed after general anaesthesia induction and before the surgery under ultrasound-guidance.

The local infiltration analgesia will be performed by the surgeon during the surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pain Anterior Cruciate Ligament Injury Anterior Cruciate Ligament Rupture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IPACK block

Saphenous nerve block and IPACK block by anesthetist under ultrasound guidance.

Group Type EXPERIMENTAL

Ropivacaine injection

Intervention Type DRUG

Saphenous nerve block with 20ml of ropivacaine 0.5% and IPACK block with 30ml of ropivacaine 0.2% (total dose of 160 mg).

Local infiltration analgesia

Periarticular infiltration by surgeon

Group Type ACTIVE_COMPARATOR

Ropivacaine injection

Intervention Type DRUG

Periarticular infiltration of 80 ml ropivacaine 0.2% (total dose of 160mg).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ropivacaine injection

Saphenous nerve block with 20ml of ropivacaine 0.5% and IPACK block with 30ml of ropivacaine 0.2% (total dose of 160 mg).

Intervention Type DRUG

Ropivacaine injection

Periarticular infiltration of 80 ml ropivacaine 0.2% (total dose of 160mg).

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Statut ASA I-III.
* Patient scheduled for anterior crutiate ligament reconstruction under general anesthesia.

Exclusion Criteria

* Pregnancy.
* Contraindication to local anesthesia.
* Patient with chronic pain, opioid consumption or alcohol consumption.
* Patient with coagulation trouble, hepatic dysfunction or renal dysfunction.
* Patient with diabetic or femoral neuropathy.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No